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HEALTH CLAIMS ON FOODS
Rationale and scientific support for
health claims on foods
The role of diet and physical activity in health has been
increasingly documented and pinpointed as a major
target for health-promoting strategies. The supply,
availability, marketing and price of food products have
a strong impact on consumers’ diets.1 Therefore,
national food and agricultural policies should be
consistent with the protection and promotion of public
health, and governments should be encouraged to
examine food and agricultural policies for potential
health effects on the food supply.2 There is already a
clear shift in many countries and regions regarding the
scope of agricultural and food policies, from a farmers’
to a consumers’ perspective. The supply of nutritious
foods with appropriate macronutrient composition,
energy density and micronutrient content is a
prerequisite for optimal nutrition and a main target for
nutrition policies. In addition to optimising the nutrient
content of foods, an increasing body of evidence
regarding effects of food components – both nutrients
and other substances – and food properties on
physiological functions, provides a basis for additional
benefits of foods on health, performance and well-
being. This is the basis for the functional foods concept
that was conceived in Japan in the late 1980s.3
The escalating cost of pharmacological treatment of
diseases and risk factors related to lifestyle factors,
such as diet and physical activity, is another
increasingly important driving force for the
development of nutritionally optimised foods. Several
recent large-scale intervention studies (e.g. Tuomilehto
et al.4 and Knowler et al.5) have demonstrated that diet
and physical activity can be at least as effective as
commonly used drugs against obesity, elevated blood
pressure and blood lipids and type 2 diabetes. The
principle of trying lifestyle changes including diet and
physical activity before introducing lifelong
pharmacological treatment of risk factors such as
elevated blood pressure and plasma cholesterol levels is
gaining acceptance and becoming common practice in
the medical community.
Health claims on foods have received increased
attention, both from the producers’ perspective as a
means of marketing foods with added value in terms of
health, and from the consumers’ point of view in terms
of consumer education and improved health. However,
there is also a risk of overemphasis of the importance of
single foods for health. Different national and
international bodies attempting to regulate this rapidly
evolving market apply various approaches, not least to
make claims compatible with and supportive of the
general nutrition recommendations. There is a broad
consensus that any regulatory framework should
protect the consumer, promote fair trade and encourage
innovation in the food industry.6
Functional foods are generally regarded as foods with
scientifically substantiated beneficial effects on health,
well-being and performance, in addition to providing
the normal nutrients.7 Rather than formally defining
functional foods, however, most national and
international bodies have discussed and defined a
number of health claims typically used for foods with
added value in terms of health, well-being and
performance. Guidelines were recently adopted by the
Codex Alimentarius Commission.8 A claim means any
representation that states, suggests or implies that a
food has particular characteristics relating to its origin,
nutritional properties, function, nature, production,
processing, composition or any other quality. The two
main types of claims are regarding: (i) what the food
contains, i.e. nutrient content claims and comparative
Functional foods are foods with
health claims
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claims; and (ii) what the product does in terms of
health, well-being and performance, i.e. health claims.9
Health claims can be: (i) generic (general) and relate to
the importance for health of the dietary composition, to
which the product can specifically contribute through
its favourable nutritional composition; or (ii) product-
specific, meaning that a certain effect on health,
performance or well-being is obtained by consuming
the particular food product.9
Codex guidelines8 specify three different types of health
claims: (i) nutrient function claims describing a
generally accepted role of a nutrient in growth,
development and normal physiological functions of the
body; (ii) other function claims – previously referred to
as enhanced function claims as suggested in the
Functional Foods Science in Europe (FUFOSE)7 project
– referring to specific beneficial effects of food and food
components on physiological and psychological
functions other than nutrient function claims as
described above; and (iii) reduction of disease risk
claims referring to the reduction in one or several risk
factors for diet-related chronic diseases, obtained by
consuming certain foods or diets. Although the
nomenclature shows some variation as seen in Table I,
these principal types of health claims are now well
established internationally.
In many countries claims about disease risk reduction,
mentioning the disease in question, are regarded as
incompatible with medical products legislation.
However, such claims have been used in the USA since
the implementation of the Nutrition Labelling and
Education Act (NLEA) in 1993 and in Canada since
2003.  Already in 1989 the Medical Products Agency in
Sweden decided, under certain conditions, no longer to
apply medical products legislation on foods ‘normally
found on the dinner table’. This paved the way for the
Food Industry’s Code of Practice introduced in
collaboration with the authorities in 1990.10 A
corresponding decision by the Commission of the
European Communities in 2003 preceded the proposal
for a regulation on nutrition and health claims for
foods.9,11
Scientific substantiation is of key importance for any
type of claim: (i) to provide truthful information and to
support consumer confidence in foods for which there
are claims; (ii) to satisfy regulatory requirements; and
(iii) to allow fair market competition. This is one of the
areas of public health nutrition where evidence-based
science is, and should be, used. The type of claim
determines the type and extent of evidence required.
For instance, a generic claim reflecting the well-
established relationship between saturated fat
intake/plasma total and low-density lipoprotein (LDL)
cholesterol levels/risk of cardiovascular disease will be
based on the same extensive documentation that
underpins the general recommendation to limit
saturated fat intake to 10% of the energy intake in most
national and international nutrition recommendations
(e.g. WHO1). Claims about a specific effect of a
proprietary food, on the other hand, would rely in the
first instance on human nutrition studies with
volunteers consuming that particular food product.9,12,13
A major European Commission (EC)-supported
concerted action project,‘Process for the Assessment of
Scientific Support for Claims on Foods (PASSCLAIM)’,
was recently concluded. The project was organised by
the International Life Science Institute (ILSI Europe)
during 2001 - 2005 and engaged more than 160
scientists from academia, industry, research institutes,
public interest groups and the regulatory environment.
The main objective was to produce a generic tool for
assessing the scientific support for health claims for
foods.
PASSCLAIM defined a number of generally applicable
criteria for the scientific support of claims, listed in
Table II. These criteria emphasise the need for direct
evidence of benefits to humans, recognise the
usefulness of markers of intermediate effects and
Scientific substantiation of claims
essential
Council of Europe Codex Alimentarius Proposed EU regulation
FUFOSE (1999) (2001) (2004) (2003)
Nutrient function claims Nutrient function claims Nutrient function claims Health claims related to 
not considered not considered the generally accepted
------------------------ --------------------------- -------------------------- role of nutrients and
Enhanced function  Enhanced function Other function other substances
claims claims claims
Disease risk  Disease risk Disease risk Health claims related to 
reduction claims reduction claims reduction claims disease risk reduction 
Table I.       Health claims classification according to FUFOSE,7 Council of Europe,12 Codex
Alimentarius Commission8 and the proposed EU regulation11 (adapted from 
Aggett et al.13)
PASSCLAIM defines the criteria























highlight that effects should be both statistically and
biologically meaningful. A consensus report13 presents
these criteria and gives an outline of the context within
which they are to be assessed. 
The context within which a claim is made should be
considered in relation to existing legislation as well as
dietary guidelines. Foods for which health claims are
made should fit into a healthy diet. Requirements on
the nutritional composition of the food product for
which a claim is made, in addition to the active
component(s), are a matter of discussion, not least
within the European Community in terms of ‘nutrition
profiling’. In any case, products for which health claims
are made should be possible to accommodate within a
balanced diet according to current nutrition
recommendations. Other important contextual points
stressed in the PASSCLAIM project are that the
regulations should in principle reflect the evolving
science base taking into account new scientific
developments as appropriate, rather than for instance
excluding certain areas a priori. An important point
outside the scope of PASSCLAIM is that a claim should
reflect its scientific basis, and, at the same time, should
be understandable, and not be misleading to the
intended consumer.13
The way to develop valid scientific study designs and
to identify, validate and use markers to explore the
effects of diet on health was dealt with by a number of
expert groups, each focused on a specific theme. Seven
comprehensive reviews on diet-related cardiovascular
disease, bone health and osteoporosis, physical
performance and fitness,14 body weight regulation,
insulin sensitivity and diabetes, diet-related cancer,
mental state and performance, and gut and immunity15
formed the basis for development of the criteria. One
study made a synthesis and review of existing
processes.9
The criteria describe the standards by which the
quality and relevance of the scientific evidence should
be judged and thus the extent to which a claim based
on them can be said to be scientifically valid.
Therefore, the criteria have the potential to increase
public confidence in the role of diet in maintaining and
improving health and well-being. 
A key issue is that substantiation of a claim should be
based on human data, primarily from intervention
studies (criterion 2, Table II). There are many forms of
human studies, which can be broadly classified into
intervention and observational. Intervention studies
include the randomised controlled trial (RCT) looking at
physiological or psychological effects. RCTs are often
the final piece of evidence for a claim, after data have
been gathered from observational and other types of
study. It is desirable to have more than one RCT
showing the effect to be claimed. Mechanisms for the
effects are desirable but not essential to know.13
Health claims on foods provide opportunities for
marketing of foods with added value in terms of health,
well-being and performance. Provided that strict
criteria for the scientific substantiation of such claims
are applied, and that the scientific evidence is
translated into clear and balanced statements
understandable for the intended consumer and taking
into account the importance of the whole diet, foods
Concluding remarks 
1.  The food or food component to which the claimed effect is attributed should be characterised.
2.  Substantiation of a claim should be based on human data, primarily from intervention studies, the design of
which should include the following considerations:
• Study groups that are representative of the target group
• Appropriate controls
• An adequate duration of exposure and follow-up to demonstrate the intended effect
• Characterisation of the study groups’ background diet and other relevant aspects of lifestyle
• An amount of the food or food component consistent with its intended pattern of consumption
• The influence of the food matrix and dietary context on the functional effect of the component
• Monitoring of subjects’ compliance concerning intake of food or food component under test
• The statistical power to test the hypothesis.
3.  When the true endpoint of a claimed benefit cannot be measured directly, studies should use markers.
4.  Markers should be:
• Biologically valid in that they have a known relationship to the final outcome and their variability within the
target population is known
• Methodologically valid with respect to their analytical characteristics.
5.  Within a study the target variable should change in a statistically significant way and the change should be
biologically meaningful for the target group consistent with the claim to be supported.
6.  A claim should be scientifically substantiated by taking into account the totality of the available data and by
weighing of the evidence.
Table II.     The PASSCLAIM criteria for the scientific substantiation of claims13













with health claims would provide well-documented
alternatives for increasingly health-conscious
consumers, for the benefit of consumer health.
Furthermore, possibilities to develop and market such
foods have the potential to focus on and promote
nutrition as a main quality parameter with resulting
improvements of the nutritional composition of a
broader range of food products for the benefit of
consumers in general. 
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CHRONIC DISEASE PREVENTION
Global strategies to prevent chronic
diseases1
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Chronic, non-communicable diseases such as heart
disease, stroke, cancer and diabetes, despite being the
leading global causes of death and disability, are
notably absent from international development
discussions and actions.  This paper makes four points.
First it reaffirms the critical importance of chronic
diseases as causes of ill health globally – and especially
in low- and middle-income countries – and their
potential, and underappreciated, constraint on
economic and social development in all countries.
Secondly, it emphasises the unrealised potential for the
prevention and control of all major chronic diseases.
Thirdly, it considers the absence of chronic diseases
from the Millennium Development Goals (MDGs) and
how best to align the chronic disease agenda with the
MDG agenda. Fourthly, it highlights the importance of
operational research to support the implementation of
global strategies for the prevention and control of
chronic diseases, rather than more epidemiological,
clinical or laboratory research.
Since the early decades of the last century chronic
diseases have been the leading causes of death and
disease in most wealthy countries.  Only recently has it
been appreciated that these diseases are now the
leading cause of death in all regions of the world,
except Africa.
This year there will be an estimated 58 million deaths,
35 million of which will be due to chronic diseases.
Approximately 16 million of these chronic disease
deaths will be premature, i.e. occurring under the age
of 70 years.  Of all chronic disease deaths 80% occur in
low- and middle-income countries, and the death rates
in these countries are considerably higher than in high-
income countries.  The burden of chronic diseases (as
measured by disability adjusted life-years) is
increasing, now accounting for nearly half of the global
burden of disease (all ages).  While the proportion of
The burden of chronic diseases
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